Association of Symptoms of Gastroesophageal Reflux with Metabolic Syndrome Parameters in Patients with Endocrine Disease
Table 3
Characteristics of subjects stratified by FSSG score.
FSSG ≤ 7
FSSG ≥ 8
for difference
Number of patients
93
18
Male (%)
26 (28.0)
4 (22.2)
0.62
Age, years
0.41
BMI, kg/m2
23.1 (20.7–25.2)
24.1 (21.2–26.5)
0.33
Waist circumference, cm
83.0 (74.0–91.0)
79.0 (75.0–93.0)
0.97
SBP, mmHg
120 (110–130)
111 (110–130)
0.33
DBP, mmHg
70 (60–80)
60 (50–70)
0.03
FBS, mg/dL
101 (89–112)
93 (85–107)
0.28
HbA1c (NGSP), %
5.6 (5.1–6.2)
5.6 (5.5–6.0)
0.69
Triglyceride, mg/dL
97 (68–144)
153 (87–274)
0.04
TC, mg/dL
203 (182–232)
203 (177–215)
0.57
HDL-C, mg/dL
57 (49–74)
55 (46–65)
0.30
Uric acid, mg/dL
5.1 (4.2–6.2)
4.9 (4.5–6.4)
0.91
Cortisol, g/dL
9.5 (6.7–14.7)
8.7 (7.0–11.9)
0.62
Free T4, ng/mL
1.26 (1.14–1.64)
1.34 (1.18–1.47)
0.89
TSH, ng/mL
1.21 (0.47–2.72)
1.37 (0.02–3.04)
0.97
IGF-1, ng/mL
240 (148–452)
250*
—
Mean ± standard deviation (SD) or median (interquartile range (IQR)). for difference was calculated by test for gender, -test for age, and Wilcoxon rank sum test for other variables.
*Only 1 person was made an evaluation of IGF-1.
